MedTrace Logo

Identification and Semi -Quantification of ER/PR Proteins Expression

NCT02654431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2016-01-13

No results posted yet for this study

Summary

The purpose of the study is the identification and quantification of proteins expression level in breast cancer tissues.

The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classifying ER/PR IHC stained samples.

Conditions

Interventions

PROCEDURE

Breast Cancer patient

Samples

PROCEDURE

Cancer patients

Samples

Sponsors & Collaborators

  • Applied Spectral Imaging Ltd.

    lead INDUSTRY

Principal Investigators

  • Sheila Dobin · Section Chief, Cytogenetics

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-05-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654431 on ClinicalTrials.gov